Cannabis Franchise pioneers Releaf Group are pleased to announce that their licensed wholesale and distribution division Releaf Dispensaries Pty Ltd, a wholly-owned subsidiary of Releaf Group Ltd launches on the 1st of November 2021 as the company’s B2B trial implementation phase comes to a successful completion.
Releaf Dispensaries will have the largest portfolio of medicinal cannabis and retail brands in Australia with over 100 independent suppliers, inclusive of Releaf Group’s exclusive retail and medicinal cannabis product lines to support their national Dispensary Franchisees and export division.
“It has taken Releaf three years to reach this major milestone which completes the execution of our B2C and B2B vertically integrated business plan. The new wholesale and distribution division will provide the company with streamlined operations, as well as provide considerable growth in revenues and earnings as the volume of Franchise sites and product sales increase across the country and abroad” said Gary Mackenzie, Releaf Group Founder and CEO.
Releaf Group has entered an exciting new growth phase as the company prepares to head towards an IPO in 2022 post COVID lockdowns in Australia with State borders imminent to open by the new year.
About Releaf: Releaf Group Ltd are Australia’s leading cannabis franchise group in the APAC region with views to expand their franchising model into international markets. The company has a vertically integrated model that incorporates cultivation, import, export and wholesale manufacturing to service its end distribution Clinics & Dispensaries.